Fig. 6.
Progression-free survival (PFS) (a) and overall survival (OS) (b) according to the renal function: eGFR ≥ 60 mL/min (n = 382), eGFR 30- < 60 mL/min (n = 85), eGFR 15- < 30 mL/min (n = 32), eGFR < 15 mL/min (n = 19). There was no difference in median PFS between patients with mild, moderate, severe renal dysfunction and renal failure/dialysis (39 vs 37 vs 46 vs 34 months; p = 0.58) and in median OS (79 vs 79 vs 75 vs 78 months; p = 0.72)